Ultra ‐Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats
The objective of the present study was to assess the antiallodynic synergistic interaction between gabapentinoids and naltrexone in rats. Oral administration of pregabalin (ED50 = 2.79 ± 0.16 mg/kg) or gabapentin (ED50 = 21.04 ± 2.87 mg/kg) as well as intrathecal naltrexone (ED50 = 0.11 ± 0.02 ng) reduced in a dose‐dependent manner tactile allodynia in rats. Maximal antiallodynic effects (∼100%) were reached with 30 mg/kg of pregabalin, 300 mg/kg of gabapentin or 0.5 ng of naltrexone. Co‐administration of pregabalin or gabapentin and naltrexone in a fixed‐dose ratio (1:1) remarkably reduced spinal nerve ligation‐induced tactile allodynia showing a synergistic interaction. The data indicate that combinations of pregabalin or gabapentin and ultra‐low doses of naltrexone are able to reduce tactile allodynia in neuropathic rats with lower doses that those used when drugs are given individually and with an improved side effects profile. Drug Dev Res, 2017. © 2017 Wiley Periodicals, Inc.
Source: Drug Development Research - Category: Drugs & Pharmacology Authors: Jorge B. Pineda ‐Farias, Nadia L. Caram‐Salas, Ana B. Salinas‐Abarca, Jorge Ocampo, Vinicio Granados‐Soto Tags: Research Article Source Type: research
More News: Back Pain | Brain | Drugs & Pharmacology | Gabapentin | Lyrica | Neurology | Neurontin | Pain | Study